As of 2026-01-15, the Relative Valuation of Utah Medical Products Inc (UTMD) is 125.57 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.92 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 113.1%.
The range of the Relative Valuation is 113.60 - 140.12 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.7x - 38.6x | 36.2x |
| Forward P/E multiples | 29.0x - 32.1x | 30.6x |
| Fair Price | 113.60 - 140.12 | 125.57 |
| Upside | 92.8% - 137.8% | 113.1% |
| Date | P/E |
| 2026-01-13 | 16.12 |
| 2026-01-12 | 16.49 |
| 2026-01-09 | 16.49 |
| 2026-01-08 | 16.17 |
| 2026-01-07 | 15.89 |
| 2026-01-06 | 15.76 |
| 2026-01-05 | 15.86 |
| 2026-01-02 | 15.56 |
| 2025-12-31 | 15.41 |
| 2025-12-30 | 15.50 |
| 2025-12-29 | 15.74 |
| 2025-12-26 | 15.63 |
| 2025-12-24 | 15.50 |
| 2025-12-23 | 15.68 |
| 2025-12-22 | 15.59 |
| 2025-12-19 | 15.58 |
| 2025-12-18 | 15.80 |
| 2025-12-17 | 15.79 |
| 2025-12-16 | 16.09 |
| 2025-12-15 | 15.83 |
| 2025-12-12 | 16.00 |
| 2025-12-11 | 15.89 |
| 2025-12-10 | 15.54 |
| 2025-12-09 | 15.32 |
| 2025-12-08 | 15.29 |
| 2025-12-05 | 15.42 |
| 2025-12-04 | 15.42 |
| 2025-12-03 | 15.32 |
| 2025-12-02 | 15.11 |
| 2025-12-01 | 15.19 |
| 2025-11-28 | 15.52 |
| 2025-11-26 | 15.33 |
| 2025-11-25 | 15.40 |
| 2025-11-24 | 15.20 |
| 2025-11-21 | 15.19 |
| 2025-11-20 | 14.81 |
| 2025-11-19 | 14.84 |
| 2025-11-18 | 15.04 |
| 2025-11-17 | 15.12 |
| 2025-11-14 | 15.25 |
| 2025-11-13 | 15.45 |
| 2025-11-12 | 15.47 |
| 2025-11-11 | 15.75 |
| 2025-11-10 | 15.77 |
| 2025-11-07 | 15.80 |
| 2025-11-06 | 15.94 |
| 2025-11-05 | 15.97 |
| 2025-11-04 | 16.04 |
| 2025-11-03 | 16.10 |
| 2025-10-31 | 16.00 |